Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS
- PMID: 2423250
- DOI: 10.1016/0092-8674(86)90778-6
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS
Abstract
To determine the extent and nature of genetic variation present in independent isolates of HTLV-III/LAV, the nucleotide sequences of the entire envelope gene and parts of gag and pol were determined for two AIDS viruses. The results indicated that variation throughout the viral genome is extensive and that the envelope gene in particular is most highly variable. Within the envelope, changes were most prevalent within the extracellular region where clustered nucleotide substitutions and deletions/insertions were evident. Based on predicted secondary protein structure and hydrophilicity, these hypervariable regions represent potential antigenic sites. In contrast to the hypervariable regions, other sequences in the extracellular envelope and the overall envelope structure (including 18 of 18 cysteine residues), as well as most of the transmembrane region, were highly conserved.
Similar articles
-
Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses.Princess Takamatsu Symp. 1984;15:147-57. Princess Takamatsu Symp. 1984. PMID: 6100635 Review.
-
BLV and HTLV-I: their unique genomic structures and evolutionary relationship.Princess Takamatsu Symp. 1984;15:229-40. Princess Takamatsu Symp. 1984. PMID: 6085845 Review.
-
Genome organization and transactivation of the human immunodeficiency virus type 2.Nature. 1987 Apr 16-22;326(6114):662-9. doi: 10.1038/326662a0. Nature. 1987. PMID: 3031510
-
Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).Science. 1985 Feb 1;227(4686):484-92. doi: 10.1126/science.2578227. Science. 1985. PMID: 2578227
-
Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus.Cell. 1985 Aug;42(1):369-82. doi: 10.1016/s0092-8674(85)80132-x. Cell. 1985. PMID: 2410140
Cited by
-
HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide.Cell Rep. 2023 Jul 25;42(7):112755. doi: 10.1016/j.celrep.2023.112755. Epub 2023 Jul 11. Cell Rep. 2023. PMID: 37436899 Free PMC article. Clinical Trial.
-
Cryo-EM structures of prefusion SIV envelope trimer.Nat Struct Mol Biol. 2022 Nov;29(11):1080-1091. doi: 10.1038/s41594-022-00852-1. Epub 2022 Nov 7. Nat Struct Mol Biol. 2022. PMID: 36344847 Free PMC article.
-
Dynamic HIV-1 spike motion creates vulnerability for its membrane-bound tripod to antibody attack.Nat Commun. 2022 Oct 27;13(1):6393. doi: 10.1038/s41467-022-34008-y. Nat Commun. 2022. PMID: 36302771 Free PMC article.
-
Novel small synthetic HIV-1 V3 crown variants: CCR5 targeting ligands.J Biochem. 2022 Sep 5;172(3):149-164. doi: 10.1093/jb/mvac052. J Biochem. 2022. PMID: 35708645 Free PMC article.
-
Small-Molecule HIV Entry Inhibitors Targeting gp120 and gp41.Adv Exp Med Biol. 2022;1366:27-43. doi: 10.1007/978-981-16-8702-0_3. Adv Exp Med Biol. 2022. PMID: 35412133 Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
